Furthermore patent expiry of insulin aspart and insulin lispro is projected to propel growth of
antidiabetic biosimilars market. Biosimilar insulin have potential to reduce diabetes treatment costs,
increase accessibility of insulin treatment and expand the number of insulin brands.
Constraints for growth of the antidiabetic biosimilars market
Biosimilars would have to face stringent regulatory requirements that would focus on their
production before entering into major markets such as the U.S. While biosimilars have marked
successful entry in the European markets, entry in the U.S. market is still a challenge due to
stringent regulatory norms. Furthermore, biosimilars would need to gain favorable reimbursement
to gain market traction.
Increasing number of diabetes patients driving the antidiabetic biosimilars market globally
Increasing incidence of diabetes, complexities in alternative diabetic therapies, and government
incentives for introduction of low cost therapies are collectively creating a conducive environment
for growth of the market. According to the International Diabetes Federation (IDF), there were
around 59.8 million diabetic patients in Europe in 2015. The market for antidiabetic biosimilar is
expected to be high in near future in Asia Pacific due to increase in research activities related to
antidiabetic products and supportive government funding. North America region is projected to
represent a lucrative market for antidiabetic biosimilar in the near future, as prevalence of diabetes
is increasing in this region. According to the International Diabetes Federation, in 2015, over 29.1
million people in the U.S. suffered from diabetes.
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-
customization/92
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]